Various diagnostic tests including conventional invasive coronary angiography and non-invasive computed tomography (CT) coronary angiography are used in the diagnosis of coronary heart disease (CHD).
and legal implications of CT coronary angiography versus invasive coronary angiography in the diagnosis of CHD.
Methods
A systematic literature search was conducted in electronic data bases (MEDLINE, EMBASE etc.) in October 2010 and was completed with a manual search. The literature search was restricted to articles published from 2006 in German or English. Two independent reviewers were involved in the selection of the relevant publications. The medical evaluation was based on systematic reviews of diagnostic studies with invasive coronary angiography as the reference standard and on diagnostic studies with intracoronary pressure measurement as the reference standard. Study results were combined in a metaanalysis with 95 % confidence intervals (CI). Additionally, data on radiation doses from current non-systematic reviews were taken into account. A health economic evaluation was performed by modelling from the social perspective with clinical assumptions derived from the metaanalysis and economic assumptions derived from contemporary German sources. Data on special indications (bypass or in-stent-restenosis) were not included in the evaluation. Only data obtained using CT scanners with at least 64 slices were considered.
Results
No studies were found regarding the clinical efficacy or prognostic value of CT coronary angiography versus conventional invasive coronary angiography in the diagnosis of CHD. Overall, 15 systematic reviews with data from 44 diagnostic studies using invasive coronary angiography as the reference standard (identification of obstructive stenoses) and two diagnostic studies using intracoronary pressure measurement as the reference standard (identification of functionally relevant stenoses) were included in the medical evaluation. Meta-analysis of the nine studies of higher methodological quality showed that, CT coronary angiography with invasive coronary angiography as the reference standard, had a sensitivity of 96 % (95 % CI: 93 % to 98 %), specificity of 86 % (95 % CI: 83 % to 89 %), positive likelihood ratio of 6.38 (95 % CI: 5.18 to 7.87) and negative likelihood ratio of 0.06 (95 % CI: 0.03 to 0.10). However, due to non-diagnostic CT images approximately 3.6 % of the examined patients required a subsequent invasive coronary angiography. Using intracoronary pressure measurement as the reference standard, CT coronary angiography compared to invasive coronary angiography had a sensitivity of 80 % (95 % CI: 61 % to 92 %) versus 67 % (95 % CI: 51 % to 78 %), a specificity of 67 % (95 % CI: 47 % to 83 %) versus 75 % (95 % CI: 60 % to 86 %), an average positive likelihood ratio of 2.3 versus 2.6, and an average negative likelihood ratio 0.3 versus 0.4, respectively. Compared to invasive coronary angiography, the average effective radiation dose of CT coronary angiography was higher with retrospective electrocardiogram (ECG) gating and relatively similar with prospective ECG gating. The health economic model using invasive coronary angiography as the reference standard showed that at a pretest probability of CHD of 50 % or lower, CT coronary angiography resulted in lower cost per patient with true positive diagnosis. At a pretest probability of CHD of 70 % or higher, invasive coronary angiography was associated with lower cost per patient with true positive diagnosis. Using intracoronary pressure measurement as the reference standard, both types of coronary angiographies resulted in substantially higher cost per patient with true positive diagnosis. Two publications dealing explicitly with ethical aspects were identified. The first addressed ethical aspects regarding the principles of beneficence, autonomy and justice, and the second addressed those regarding radiation exposition, especially when used within studies.
Discussion
The discriminatory power of CT coronary angiography to identify patients with obstructive (above 50 %) coronary stenoses should be regarded as "high diagnostic evidence", to identify patients without coronary stenoses as "persuasive diagnostic evidence". The discriminatory power of both types of coronary angiography to identify patients with or without functionally relevant coronary stenoses should be regarded as "weak diagnostic evidence". It can be assumed that patients with a high pretest probability of CHD will need invasive coronary angiography and patients with a low pretest probability of CHD will not need subsequent revascularisation. Therefore, CT coronary angiography may be used before performing invasive coronary angiography in patients with an intermediate pretest probability of CHD. For identifying or excluding of obstructive coronary stenosis, CT coronary angiography was shown to be more cost-saving at a pretest probability of CHD of 50 % or lower, and invasive coronary angiography at a pretest probability of CHD of 70 % or higher. The use of both types of coronary angiography to identify or to exclude functionally relevant coronary stenoses should be regarded as highly cost-consuming. With regard to ethical, social or legal aspects, the following possible implications were identified: under-provision or over-provision of health care, unnecessary complications, anxiety, social stigmatisation, restriction of self-determination, unequal access to health care, unfair resource distribution and legal disputes.
Conclusion
From a medical point of view, CT coronary angiography using scanners with at least 64 slices should be recommended as a test to rule out obstructive coronary stenoses in order to avoid inappropriate invasive 2/16 GMS Health Technology Assessment 2012, Vol. 8, ISSN 1861-8863 coronary angiography in patients with an intermediate pretest probability of CHD. From a health economic point of view, this recommendation should be limited to patients with a pretest probability of CHD of 50 % or lower. From a medical and health economic point of view, neither CT coronary angiography using scanners with at least 64 slices nor invasive coronary angiography may be recommended as a single diagnostic test for identifying or ruling out functionally relevant coronary stenoses. To minimise any potential negative ethical, social and legal implications, the general ethical and moral principles of benefit, autonomy and justice should be considered.
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Summary Health political and scientific background
Coronary heart disease (CHD) is one of the most common clinical disorders of great epidemiological and economic importance. CHD is associated with symptoms of reduced blood supply to the heart muscle (e. g., angina pectoris) and increased risk of thrombotic events (e. g., myocardial infarction). Various tests are used in the diagnosis of CHD, including coronary angiography with cardiac catheterisation, also referred to as conventional invasive coronary angiography and coronary angiography without cardiac catheterisation, also referred to as computed tomography (CT) coronary angiography. Since coronary arteries are very small vessels that move rapidly because of heart muscle contractions, CT coronary angiography must fulfil high technical requirements to avoid distorted images. Due to its ability to assess coronary stenoses and its potential for immediate quality control of the performed revascularisation, invasive coronary angiography is currently regarded as the "gold standard" for diagnosis of stenosisrelated CHD. However, a subsequent coronary intervention is performed in only about 40 % of the invasive coronary angiographies. In addition, invasive coronary angiography is associated with the risk of serious complications. Therefore, a non-invasive test capable of reliably verifying or excluding functionally or prognostically relevant coronary stenoses should be able to replace invasive coronary angiography and, probably, other diagnostic tests. Especially due to its lower risk of complications and higher potential for prediction of severe cardiovascular events (owing to the assessment of not-calcified vulnerable plaques prone to rupture), CT coronary angiography could play an increasing role in the diagnosis of CHD and treatment decision-making. Currently, CT coronary angiography is primarily being discussed as a test to exclude obstructive (over 50 %) coronary artery stenoses and, therefore, to avoid invasive coronary angiography in a large number of patients. However, both diagnostic tests provide only limited information about the functional relevance of the identified stenoses and about their predictive value for future coronary events. Therefore, the value of both types of coronary angiographies for CHD diagnosis as well as for revascularisation decision-making has been challenged. The present report aims to compare the effectiveness, side effects, radiation dose, diagnostic and prognostic value, costs and cost-effectiveness of conventional invasive coronary angiography versus CT coronary angiography as well as to identify ethical, social and legal implications based on a systematic review of the literature.
Research questions Medical evaluation
What are the clinical efficacy, diagnostic accuracy and prognostic value of CT coronary angiography compared to that of conventional invasive coronary angiography in the diagnosis of CHD?
Health economic evaluation
What are the costs of CT coronary angiography compared to that of conventional invasive coronary angiography in relation to clinical efficacy, diagnostic accuracy or prognostic value in the diagnosis of CHD?
Ethical, social and legal evaluation Which ethical, social and legal implications should be considered in the use of CT coronary angiography or conventional invasive coronary angiography in the diagnosis of CHD?
Methods

Medical evaluation
The literature search was conducted in medical electronic databases (MEDLINE, EMBASE etc.) in October 2010 and was completed with a manual search. The search was restricted to articles published from 2006 in German or English. Two independent reviewers were involved in the selection of the relevant publications. Primarily, systematic reviews of controlled clinical, diagnostic or prognostic studies comparing CT coronary angiography with invasive coronary angiography in the diagnosis of CHD were selected from the identified hits. The addressed endpoints were mortality, morbidity as well as parameters of diagnostic and prognostic value. Secondly, the identified hits were screened to identify controlled clinical studies and prognostic studies comparing CT coronary angiography and invasive coronary angiography in the diagnosis of CHD. Additionally, hits were screened for diagnostic studies using intracoronary pressure measurement or intravascular ultrasound as the reference standard. Systematic reviews and studies on special indications (bypass or in-stent-restenosis) as well as abstracts and segment-based analyses were not included in the evaluation. Only data obtained using CT scanners with at least 64 slices were considered for inclusion. Additionally, data on radiation doses from current non-systematic reviews were also taken into account. The selected systematic reviews were evaluated for risk of bias. The pool of the included diagnostic studies was checked, and the quality of the studies was assessed using information in the systematic reviews. Using data from studies presented in these reviews, a meta-analysis was conducted only for data obtained using 64-slice CT scanners. The meta-analysis was performed to determine the sensitivity, specificity, positive likelihood ratio (LR+) and negative likelihood ratio (LR-) by calculating the 95 % confidence interval (CI) in the random effects model using the Meta-DiSc programme. The area under the curve (AUC) of the receiver operating characteristic curve (ROC) was also assessed. Due to the heterogeneity of the study results, a meta-analysis was also conducted for studies of higher methodological quality. The identified diagnostic studies using intracoronary pressure measurement as the reference standard were also evaluated methodologically. The synthesis of the information from these studies was performed qualitatively. Additionally, the proportions of patients with true positive or true negative diagnoses as well as the effective radiation doses were calculated as a function of pretest probability for different scenarios of CT coronary angiography or of invasive coronary angiography, using in each scenario invasive coronary angiography or intracoronary pressure measurement as the reference standard.
Health economic evaluation
The literature search was conducted in health economic relevant medical electronic databases in October 2010. The search was restricted to articles published from 2006 in German or English. Two independent reviewers were involved in the selection of the relevant publications. Systematic reviews of studies with health economic analyses, health economic studies or models comparing CT angiography with invasive coronary angiography in the diagnosis of CHD for the German health system based on assumptions from systematic reviews were selected from the identified hits. The addressed endpoints were costs and cost-effectiveness. Health economic evaluations on special indications (bypass or in-stent-restenosis), abstracts and segment-based analyses were not included in the evaluation. Only data obtained using CT scanners with at least 64 slices were considered for inclusion. The objectives, methods, results and conclusions of the identified health economic studies were described. Health economic modelling was performed to estimate the total cost per patient and the cost per patient with true positive diagnosis for CT coronary angiography and invasive coronary angiography as a function of pretest probability for different scenarios, using invasive coronary angiography or intracoronary pressure measurement as the reference standard. The clinical assumptions used in modelling were predominantly derived from the medical evaluation (e. g., for sensitivity, specificity). The costs were observed from the social perspective and were derived from contemporary German sources.
Ethical, social and legal evaluation
The conducted literature search also aimed to identify publications dealing explicitly with ethical, social or legal aspects of using CT coronary angiography and invasive coronary angiography in CHD diagnosis. Identified publications were described. Synthesis of information was performed qualitatively.
Results
Medical evaluation
Results of the literature search
The systematic literature search yielded 1,913 hits. Overall, 15 systematic reviews and two diagnostic studies were included in the medical evaluation.
Clinical efficacy and prognostic value
No studies were found on the clinical efficacy or prognostic value of CT coronary angiography in comparison to conventional invasive coronary angiography in the diagnosis of CHD.
Diagnostic accuracy using invasive coronary angiography as the reference standard
To assess the diagnostic accuracy of CT coronary angiography using invasive coronary angiography as the reference standard (identification of obstructive coronary stenoses), 15 systematic reviews with data from 44 studies obtained using at least 64 slices CT scanners were evaluated. Meta-analysis of the nine studies of higher methodological quality showed that CT coronary angiography had a sensitivity of 96 % (95 % CI: 93 % to 98 %), specificity of 86 % (95 % CI: 83 % to 89 %), LR+ of 6.38 (95 % CI: 5.18 to 7.87) and LR-of 0.06 (95 % CI: 0.03 to 0.10). The AUC of the ROC curve was 0.962 ± 0.023 and the Q* value 0.91 ± 0.03 (average ± standard error). However, due to non-diagnostic CT images approximately 3.6 % of the examined patients required a subsequent invasive coronary angiography.
Diagnostic accuracy using intracoronary pressure measurement as the reference standard
Regarding the comparison of CT coronary angiography and invasive coronary angiography using intracoronary pressure measurement as the reference standard (identification of functionally relevant coronary stenoses), two studies were identified and data from one study were found to be applicable. Sensitivity was 80 % (95 % CI: 61 % to 92 %) versus 67 % (95 % CI: 51 % to 78 %), specificity 67 % (95 % CI: 47 % to 83 %) versus 75 % (95 % CI: 60 % to 86 %), average LR+ 2.3 versus 2.6, and average LR-0.3 versus 0.4, respectively.
Comparison of diagnostic accuracy using invasive coronary angiography as the reference standard versus intracoronary pressure measurement as the reference standard Due to lower sensitivity and lower specifity of both types of coronary angiography using intracoronary pressure measurement as the reference standard compared to invasive coronary angiography as the reference standard, the proportions of patients with true positive and/or true negative diagnoses were lower. Generally, less than 80 % of patients were classified correctly by CT coronary angiography as well as invasive coronary angiography using intracoronary pressure measurement as the reference standard. This proportion was definitely lower compared to that using invasive coronary angiography as the reference standard.
Contrast medium dose and radiation dose
No comparative meta-analysis of CT coronary angiography and invasive coronary angiography was found regarding contrast medium dose and effective radiation dose. The average contrast medium dose calculated from 43 studies using CT scanners with more than 16 slices was 31.3 g, the average effective radiation dose calculated from 29 studies using CT scanners with more than 16 slices and retrospective electrocardiogram (ECG) gating was 13.0 mSv. The effective radiation doses of invasive coronary angiography and of CT coronary angiography with prospective ECG gating (approximately 5 to 7 mSv and 2 to 4 mSv, respectively; data derived from non-systematic reviews) were on average lower than those of CT coronary angiography with retrospective ECG gating. Considering the strategy of CT coronary angiography with subsequent invasive coronary angiography in case of positive findings, the average effective dose rose with increasing pretest probability of CHD. Compared to invasive coronary angiography, the average effective radiation dose of CT coronary angiography with prospective ECG gating was relatively similar.
Health economic evaluation Results of the literature search
The systematic literature search yielded 97 hits. After screening the full texts, only one publication was included in the health economic evaluation.
Appraisal of the included study
At a pretest probability of CHD of 50 % or lower, the study revealed that CT coronary angiography was associated with lower cost per correctly diagnosed patient with obstructive coronary stenosis. At a pretest probability of 70 % or higher, invasive coronary angiography resulted in lower cost per correctly diagnosed patient with obstructive coronary stenosis.
Results of health economic modelling
Comparison of CT coronary angiography with invasive coronary angiography using invasive coronary angiography as the reference standard revealed that the total cost per patient diagnosed using CT coronary angiography increases as a function of pretest probability of CHD. The curves for total cost per patient for both diagnostic tests intersected at an approximately 60 % pretest probability of CHD. At a pretest probability of CHD of 50 % or lower, CT coronary angiography resulted in lower cost per patient with true positive diagnosis. At a pretest probability of CHD of 70 % or higher, invasive coronary angiography was associated with lower cost per patient with true positive diagnosis. Use of intracoronary pressure measurement as the reference standard affected the results considerably compared to those using invasive coronary angiography as the reference standard. Both types of coronary angiographies showed a substantial increase in total cost per patient and in total cost per patient with true positive diagnosis, particularly at a low pretest probability of CHD.
Ethical, social and legal evaluation
Two publications were identified. The first publication dealt with ethical considerations in the use of CT coronary angiography. The ethical aspects were discussed within the scope of the three ethical principles beneficence, autonomy and justice. The second publication addressed primarily the ethical implications of CT coronary angiography with regard to radiation exposure, particularly when used within studies.
Discussion Medical evaluation Methodological aspects
Various methodological aspects relating to the literature search, the identified systematic reviews, the diagnostic studies and the performed synthesis of information can bias the results of medical evaluation. The validity of the conducted meta-analyses depends on the validity of each diagnostic study and the validity of the combined results derived from studies with somewhat different populations and technology modifications. Invasive coronary angiography is a reliable reference standard for the identification of coronary stenoses, whereas intracoronary pressure measurement for the detection of functionally relevant stenoses. However, both tests are not convincing with regard to prognostic value.
Interpretation of the results
The clinical efficacy and prognostic value of CT coronary angiography versus invasive coronary angiography in the diagnosis of CHD cannot be estimated based on the current data since the corresponding studies are lacking. The discriminatory power of CT coronary angiography to identify patients with obstructive coronary stenoses (according to LR+) should be regarded as "high diagnostic evidence", and its power to identify patients without obstructive coronary stenoses (according to LR-) as "excellent diagnostic evidence". Therefore, CT coronary angiography using scanners with at least 64 slices should be considered as a test for the exclusion of obstructive coronary stenoses. However, it can be assumed that patients with a high pretest probability of CHD will need invasive coronary angiography and patients with a low pretest probability will not need subsequent revascularisation. Therefore, CT coronary angiography may be used before performing invasive coronary angiography in patients with an intermediate pretest probability of CHD. For identifying patients with or without functionally relevant stenoses, the discriminatory power of CT coronary angiography and of invasive coronary angiography should be regarded only as "weak diagnostic evidence". As only two small and not methodologically flawless studies were available, their results should be regarded with great caution. Nevertheless, these data should be seen as a warning against the excessive use of coronary angiography without reliable blood flow assessment. The obtained results reflect the rapid development of CT coronary angiography with regard to the reduction of radiation dose. The effective radiation dose of CT coronary angiography with prospective ECG gating is similar to that of invasive coronary angiography.
Health economic evaluation Methodological aspects
Various methodological aspects relating to the literature search and the modelling methods can bias the results of health economic modelling. The use of clinical assumptions from a contemporary meta-analysis and cost assumptions for the German health system enables a high level of evidence of the health economic modelling and to avoid problems of transferability of the results.
Interpretation of the results
The cost per avoided cardiovascular event or per qualityadjusted life-year gained of CT coronary angiography in comparison to invasive coronary angiography in the diagnosis of CHD cannot be determined based on the current data since the corresponding studies are lacking. For identifying or excluding obstructive coronary stenosis, CT coronary angiography was shown to be more costsaving at a pretest probability of CHD of 50 % or lower, and invasive coronary angiography at a pretest probability of CHD of 70 % or higher. The use of each type of coronary angiography to identify or to exclude functionally relevant coronary stenoses should be regarded as highly cost-consuming. However, parameters of diagnostic accuracy were derived from a single small study, limiting the conclusiveness of the analysis.
Ethical, social and legal evaluation
With regard to ethical, social or legal aspects, the following possible implications were derived from the analysed publications: under-provision or over-provision of health care, unnecessary complications, anxiety, social stigmatisation, restriction of self-determination, unequal access to health care, unfair resource distribution and legal disputes. No data were found in the publications concerning differences between CT coronary angiography and invasive coronary angiography with regard to ethical, social or legal implications not related to differences in diagnostic accuracy.
Conclusions
From a medical point of view, CT coronary angiography using scanners with at least 64 slices should be recommended as a test to rule out obstructive coronary stenoses in order to avoid inappropriate invasive coronary angiography in patients with an intermediate pretest probability of CHD. From a health economic point of view, this recommendation should be limited to patients with a pretest probability of CHD of 50 % or lower. From a medical and health economic point of view, neither CT coronary angiography using scanners with at least 64 slices nor invasive coronary angiography may be recommended as a single diagnostic test for identifying or ruling out functionally relevant coronary stenoses. To minimise any potential negative ethical, social and legal implications, the general ethical-moral principles of benefit, autonomy and justice should be considered. 
CT-Koronarangiografie versus konventionelle invasive
Fragestellung Medizinische Bewertung
Wie ist die medizinische Wirksamkeit, die diagnostische Genauigkeit sowie die prognostische Güte der CT-Koronarangiografie im Vergleich zu konventioneller invasiver Koronarangiografie bei der Diagnostik der KHK?
Gesundheitsökonomische Bewertung
Wie sind die Kosten der CT-Koronarangiografie im Vergleich zu denen konventioneller invasiver Koronarangiografie in Relation zu medizinischer Wirksamkeit, diagnostischer Genauigkeit oder prognostischer Güte bei der Diagnostik der KHK?
Ethische, soziale und juristische Bewertung Welche ethischen, sozialen und juristischen Implikationen sind beim Einsatz der CT-Koronarangiografie oder der konventionellen invasiven Koronarangiografie bei der Diagnostik der KHK zu beachten?
Methodik Medizinische Bewertung
Die Literaturrecherche wird in medizinischen elektronischen Datenbanken (MEDLINE, EMBASE etc.) 
Medizinische Wirksamkeit und prognostische Güte
Es liegen keine Studien zur medizinischen Wirksamkeit und zur prognostischen Güte der CT-Koronarangiografie im Vergleich zu konventioneller invasiver Koronarangiografie bei der Diagnostik der KHK vor.
Diagnostische Güte bezogen auf den Referenzstandard invasive Koronarangiografie
Zur Ermittlung der diagnostischen Güte der CT-Koronarangiografie bezogen auf den Referenzstandard invasive Koronarangiografie (Identifikation obstruktiver Koronarstenosen) werden 15 systematische Übersichten mit Daten aus 44 Studien mit mindestens 64-zeiligen Geräten ausgewertet. Die durch die Metaanalyse der neun methodisch besseren Studien ermittelte Sensitivität für CT-Koronarangiografie beträgt 96 % (95 % CI: 93 % bis 98 %), die Spezifität 86 % (95 % CI: 83 % bis 89 %), die LR+ 6,38 (95 % CI: 5,18 bis 7,87) und die LR-0,06 (95 % CI: 0,03 bis 0,10). Die AUC der ROC-Kurve liegt bei 0,962 ± 0,023 und der Q*-Wert bei 0,91 ± 0,03 (jeweils Mittelwert ± Standardfehler). Aufgrund nicht auswertbarer CT-Koronarangiografien werden allerdings circa 3,6 % der Patienten trotzdem noch mittels einer invasiven Koronarangiografie untersucht. 
Kontrastmittelmenge und Strahlendosis
Eine vergleichende Metaanalyse der CT-Koronarangiografie und der invasiven Koronarangiografie zur Kontrastmittelmenge und zur effektiven Strahlendosis fehlt. Die verbrauchte durchschnittliche Kontrastmittelmenge beträgt laut Angaben aus 43 Studien für mehr als 16-zeilige CTGeräte 31,3 g, die durchschnittliche effektive Strahlendosis liegt laut Angaben aus 29 Studien für mehr als 16-zeilige CT-Geräte mit retrospektivem Elektrokardiogramm (EKG)-Gating bei 13,0 mSv. Die effektive Strahlendosis bei der invasiven Koronarangiografie und bei der CT-Koronarangiografie mit prospektivem EKG-Gating ist im Vergleich zur CT-Koronarangiografie mit retrospektivem EKG-Gating im Durchschnitt niedriger (ca. 5 bis 7 mSv vs. 2 bis 4 mSv; Daten stammen aus nicht systematischen Übersichten). Bei der Betrachtung der Strategie mit CT-Koronarangiografie und anschließender invasiver Koronarangiografie bei positivem Befund zeigt sich eine Steigerung der durchschnittlichen effektiven Dosis bei steigernder Prätestwahrschein-lichkeit für KHK. Verglichen mit invasiver Koronarangiografie ist die durchschnittliche effektive Strahlendosis bei der CT-Koronarangiografie mit prospektivem EKGGating relativ ähnlich.
Gesundheitsökonomische Bewertung Ergebnisse der Literaturrecherche
Die systematische Literaturrecherche ergibt insgesamt 97 Treffer. Nach der Durchsicht im Volltext wird nur eine Publikation in die gesundheitsökonomische Bewertung einbezogen.
Bewertung der einbezogenen Studie
Die Studie zeigt, dass bis einschließlich 50%iger Prätest-wahrscheinlichkeit für KHK die CT-Koronarangiografie und ab 70%iger Prätestwahrscheinlichkeit für KHK die invasive Koronarangiografie kostengünstigerer pro korrekt diagnostiziertem Patienten mit obstruktiver Koronarstenose ist.
Ergebnisse der gesundheitsökonomischen Modellierung
Beim Vergleich der CT-Koronarangiografie und der invasiven Koronarangiografie bezogen auf den Referenzstandard invasive Koronarangiografie zeigen sich steigende Gesamtkosten pro Patienten bei der Diagnostik durch die CT-Koronarangiografie in Abhängigkeit von der Prä-testwahrscheinlichkeit für KHK mit einer Überschneidung der Kurven für anfallende Gesamtkosten pro Patienten für beide Diagnostikverfahren bei circa 60%iger Prätest-wahrscheinlichkeit. Bei der Prätestwahrscheinlichkeit für KHK bis einschließlich 50 % sind die Kosten der CT-Koronarangiografie und bei der Prätestwahrscheinlichkeit ab 70 % die der invasiven Koronarangiografie niedriger pro richtig positiv diagnostiziertem Patienten. Bei der Betrachtung der beiden Koronarangiografietypen bezogen auf den Referenzstandard intrakoronare Druckmessung ändert sich das Bild im Vergleich zum Referenzstandard invasive Koronarangiografie erheblich, mit deutlicher Zunahme der Gesamtkosten pro Patienten und der Gesamtkosten pro richtig positiv diagnostiziertem Patienten, insbesondere im Bereich der niedrigen Prätest-wahrscheinlichkeit für KHK.
Ethische, soziale und juristische Bewertung
Es werden zwei Publikationen identifiziert. Eine Publikation befasst sich mit ethischen Überlegungen bei der Anwendung der CT-Angiografie. Die ethischen Gesichtspunkte werden im Rahmen der drei ethischen Prinzipien Wohltat, Autonomie und Gerechtigkeit betrachtet. Die zweite Publikation widmet sich den ethischen Implikationen der CT-Koronarangiografie vorrangig in Bezug auf die Bestrahlungsexposition, insbesondere bei der Anwendung innerhalb von Studien.
Diskussion Medizinische Bewertung Methodische Aspekte
Verschiedene methodische Aspekte der Literaturrecherche, der identifizierten systematischen Übersichten, der diagnostischen Studien und der durchgeführten Informationssynthese können die Ergebnisse der medizinischen Bewertung verzerren. Die Validität der durchgeführten Metaanalysen hängt von der Validität der einzelnen diagnostischen Studien und der Kombinierbarkeit der Studienergebnisse für etwas unterschiedliche Populationen und Technologiemodifikationen ab. Die invasive Koronarangiografie ist ein zuverlässiger Referenzstandard zur Identifikation von Koronarstenosen, die intrakoronare Druckmessung von funktionell relevanten Koronarstenosen. Beide Tests sind allerdings nur eingeschränkt aussagekräftig in Bezug auf die Prognose.
Interpretation der Ergebnisse
Die medizinische Wirksamkeit und die prognostische Güte der CT-Koronarangiografie im Vergleich zu invasiver Koronarangiografie bei der Diagnostik der KHK können aus heutiger Datenlage nicht beurteilt werden, da entsprechende Studien fehlen. Die Trennschärfe der CT-Koronarangiografie zur Identifikation von Patienten mit obstruktiven Koronarstenosen (entsprechend LR+) ist als "hohe diagnostische Evidenz", zur Identifikation von Patienten ohne obstruktive Koronarstenosen (entsprechend LR-) als "überzeugende diagnostische Evidenz" zu betrachten. Somit ist die CT-Koronarangiografie mit mindestens 64-zeiligen Geräten als Test zum Ausschluss obstruktiver Koronarstenosen anzusehen. Da bei Patienten mit hoher Prätestwahrscheinlichkeit für KHK von der notwendigen Durchführung einer invasiven Koronarangiografie und bei Patienten mit niedriger Prä-testwahrscheinlichkeit von einem fehlenden Bedarf an anschließender Revaskularisation auszugehen ist, wäre die CT-Koronarangiografie als Vorschalttest vor invasiver Koronarangiografie bei Patienten mit mittlerer Prätest-wahrscheinlichkeit für KHK anwendbar. Zur Identifikation von Patienten mit bzw. ohne funktionell relevante Stenosen ist sowohl die Trennschärfe der CTKoronarangiografie als auch die der invasiven Koronarangiografie nur als "schwache diagnostische Evidenz" zu betrachten. Da hierzu nur zwei kleine und methodisch nicht einwandfreie Studien vorliegen, sollen diese Ergebnisse mit entsprechender Vorsicht betrachtet werden. Trotzdem sind diese Daten als Warnung vor einem über-mäßigen Einsatz der Koronarangiografien ohne eine zuverlässige Durchblutungsdiagnostik zu bewerten. Die ermittelten Ergebnisse spiegeln die raschen Entwicklungen bei der CT-Koronarangiografie hinsichtlich der Reduktion der Strahlendosis wider. Die effektive Strahlendosis der CT-Koronarangiografie mit prospektivem EKG-Gating ähnelt der effektiven Strahlendosis der invasiven Koronarangiografie.
Gesundheitsökonomische Bewertung Methodische Aspekte
Verschiedene methodische Aspekte der Literaturrecherche und der Modellierung können die Ergebnisse der gesundheitsökonomischen Modellierung verzerren. Die Verwendung der klinischen Annahmen aus einer aktuellen Metaanalyse sowie der Kostenannahmen für das deutsche Gesundheitssystem ermöglicht einen hohen Evidenzgrad der gesundheitsökonomischen Modellierung und vermeidet Probleme der Übertragbarkeit für die ermittelten Ergebnisse.
Interpretation der Ergebnisse
Die Kosten pro vermiedenem kardiovaskulären Ereignis bzw. pro gewonnenem qualitätsadjustierten Lebensjahr beim Einsatz der CT-Koronarangiografie im Vergleich zu invasiver Koronarangiografie im Rahmen der KHK-Diagnostik kann aus heutiger Datenlage nicht beurteilt werden, da entsprechende Studien fehlen. Zur Identifikation bzw. zum Ausschluss von obstruktiven Koronarstenosen zeigt sich, dass bei der Prätestwahr-scheinlichkeit für KHK bis 50 % die CT-Koronarangiografie und ab 70 % die invasive Koronarangiografie kostengüns-tigerer ist. Es ist von einem übermäßigen Kostenverbrauch beim Einsatz der jeweiligen Koronarangiografietypen zur Identifikation bzw. zum Ausschluss der funktionell relevanten Koronarstenosen auszugehen. Allerdings stammen entsprechende Parameter der diagnostischen Güte aus einer kleinen Einzelstudie, was die Aussagekraft der Analyse einschränkt.
Ethische, soziale und juristische Bewertung
Aus der Zusammenschau der Publikationen lassen sich in Bezug auf ethische, soziale oder juristische Aspekte einige mögliche Implikationen ableiten: Unter-bzw. Überversorgung mit Gesundheitsleistungen, unnötige Komplikationen, Verängstigung und Stigmatisierung der Patienten, Einschränkung der Selbstbestimmung, ungleicher Zugang zur medizinischen Versorgung, ungerechte Ressourcenverteilung sowie juristische Auseinandersetzungen. Es finden sich in diesen Quellen keine Hinweise für Unterschiede der CT-Koronarangiografie und der invasiven Koronarangiografie bezüglich ethischer, sozialer oder juristischer Implikationen, die über Auswirkungen einer abweichenden diagnostischen Güte hinausgehen.
